SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

New Consenting SOP

August 24, 2022 - SCI Communications

New SOP “Consenting Research Participants and Legally Authorized Representatives” Effective 12 September 2022

A new SCI SOP “Consenting Research Participants and Legally Authorized Representatives” will be effective on 12 September 2022. 

This new SOP consolidates multiple SCI SOPs that we currently have related to the consenting process. Specifically, the procedures currently addressed in SCI SOPs Informed Consent for Adult, English-speaking Participants (Initial and Re-Consent), Legally Authorized Representative (LAR) in Informed Consent and Remote Consent of Research Participants were included in this single SOP. The goal was to provide all the relevant procedures related to consenting in a single SOP. The procedures are not substantively changed with the exception of greater clarification of consenting participants with impaired decision-making capacity. 

Please review this updated SOP prior to the effective date of 12 September 2022 at https://med.stanford.edu/ccto/services/regulatory.html#sops_guidelines and attest to your mastery of the information in the SOP confirmation form available on the same webpage.

Questions regarding this new SOP should be directed to DSMC-Quality@stanford.edu 

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube